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Abstract The Xenopus melatonin receptor was expressed in 
human embryonic kidney 293 cells and assayed for cAMP accu- 
mulation. In transfected 293 cells expressing the melatonin recep- 
tor, melatonin dose-dependently inhibited the endogenous ade- 
nylyi cyclases. In contrast, melatonin stimulated the accumula- 
tion of cAMP in cells co-expressing the type II adenylyl cyclase. 
Both the inhibitory and stimulatory responses to melatonin were 
mediated via Gi-like proteins as they were blocked by pertussis 
toxin. Upon co-transfection with the oz subunit of G~, the ability 
of melatonin to regulate both type H and the endogenous adenylyl 
cyclases became refractory to pertussis toxin, indicating that the 
melatonin receptor can also couple to Gz. However, other pertus- 
sis toxin-insensitive G proteins such as Gq, G~2 and G13 were 
unable to interact with the melatonin receptor. 
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1. Introduction 
Melatonin (N-acetyl-5-methoxytryptamine) plays an impor- 
tant role in the regulation of circadian rhythms as well as many 
physiological functions in mammals [1]. The recent cloning of 
the melatonin receptor from Xenopus [2] and rat [3] has con- 
firmed the long-suspected notion that this receptor belongs to 
the superfamily of G protein-coupled receptors. Numerous re- 
ports suggest hat melatonin can inhibit adenylyl cyclase via 
pertussis toxin (PTX) sensitive Gi-like proteins [4,5]. Expression 
of the cloned melatonin receptors in NIH-3T3 and CHO cells 
has revealed that this receptor can indeed inhibit adenylyl 
cyclase in a PTX-sensitive manner [2,3]. 
The complexity of G protein-mediated signal transduction 
networks has increased tremendously with the isolation of large 
numbers of signaling molecules exhibiting very similar func- 
tions. Multiple G protein subunits [6] and many isoforms of 
adenylyl cyclase [7] have now been identified. In order to fully 
appreciate he physiological importance ofmelatonin, it is nec- 
essary to examine the functional capability of the melatonin 
receptor to regulate diverse signaling pathways. An increasing 
number of Gi-coupled receptors have been shown to share the 
ability to stimulate type II adenylyl cyclase (AC II) as well as 
to interact with the PTX-insensitive G protein, Gz. Thus far, 
this group of G~-coupled receptors include the ~2-adrenergic, 
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dopamine-D2, adenosine-A1, formyl peptide, complement C5a, 
and all three types of opioid receptors [8-12]. Although there 
is no indication of melatonin-mediated stimulation of adenylyl 
cyclase nor of possible coupling to PTX-insensitive G proteins, 
it is conceivable that the melatonin receptor may behave like 
the other G~-coupled receptors. In this study, we report hat the 
Xenopus melatonin receptor is capable of stimulating AC II in 
a PTX-senitive manner. Moreover, we present evidence that the 
melatonin receptor can interact with the PTX-insensitive G
protein, G ,  but not with other PTX-insensitive G proteins uch 
as Gq, 612, and Gl3. 
2. Experimental 
2.1. Materials' 
The cDNA encoding Xenopus melatonin receptor [2], a generous gift 
from Dr. Steve Reppert (Massachusetts General Hospital, Boston), was 
subcloned into pcDNAI (Invitrogen) at EeoRI sites, cDNAs encoding 
the ~ subunit of G~2 and Gt3 in pCIS were kindly provided by Dr. 
Melvin Simon (California Institute of Technology, Pasadena). The 
cDNA encoding AC II in pcDNAI was from Dr. Randall Reed (Johns 
Hopkins University, MD). Other eDNAs were constructed or obtained 
as previously described [13]. PTX was purchased from List Biological 
Laboratories (Campbell, CA). Human choriogonadotropin (hCG) was 
supplied by the National Pituitary Agency (Bethesda, MD). [2-3H]Ad - 
enine was purchased from Amersham Corp. Plasmid purification col- 
umns were obtained from Qiagen Inc. Cell culture reagents were ob- 
tained from Gibco and all other chemicals were purchased from Sigma. 
2.2. Transient transfection of 293 cells 
The human embryonic kidney 293 cells (ATCC CRL-1573) were kept 
in Eagle's minimum essential medium (MEM) with 10% fetal calf serum 
(FCS), 50 units/ml penicillin and 50/~g/ml streptomycin, and in 5% 
CO2. Cells were seeded in 12-well plates at 2 x 105 cells per well and were 
transfected 24 h later with various cDNAs by the DEAE-Dextran 
method as described previously [14]. 
2.3. cAMP accumulation 
293 cells were labelled 16-20 h post-transfection with [2-3H]adenine 
(1 ~tCi/ml) in MEM with 1% FCS. When needed, PTX (100 ng/ml) was 
added simultaneously. 18 24 h later, the cells were assayed in 20 mM 
HEPES-buffered MEM (pH 7.4) containing the appropriate drugs and 
1 mM 1-methyl-3-isobutylxanthine for 30 rain at 37°C. The reaction 
was stopped by adding 5% TCA containing 1mM ATE Intracellular 
[3H]cAMP was determined by sequential chromatography [14]. Abso- 
lute values for cAMP accumulation varied between experiments, but 
variability within a given experiment was less than 10% in general. 
3. Results and discussion 
The cloned Xenopus melatonin receptor has been shown to 
inhibit adenylyl cyclase in transfected CHO cells [2]. We first 
begun by ensuring that the Xenopus melatonin receptor behaves 
similarly in transfected human embryonic kidney 293 cells. The 
293 cells were co-transfected with cDNAs encoding the rat 
luteinizing hormone receptor (LHR) [15] and the Xenopus 
melatonin receptor. By co-expressing LHR with the melatonin 
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Fig. 1. Melatonin-mediated inhibition of cAMP accumulation i trans- 
fected 293 cells. 293 cells were co-transfected with cDNAs encoding the 
LHR (0.15/tg/ml) and melatonin receptor (0.25/ag/ml). (A) Transfected 
cells were labelled with [2-3H]adenine (1 ~tCi/ml) in the absence or 
presence of PTX (100 ng/ml) and assayed for responses to hCG (5 
ng/ml) with or without melatonin (100 nM). *Melatonin significantly 
reduced the hCG-stimulated activity; paired t-test, P < 0.05. (B) Trans- 
fected cells were assayed for cAMP accumulation after exposure to 
varying concentrations ofmelatonin (from 1 pM to 10/zM). Results are 
expressed as percent inhibition of the hCG-stimulated activity as com- 
pared with that measured in the absence of melatonin. Melatonin (100 
nM) significantly inhibited the hCG-stimulated activity at concentra- 
tions > 1 nM; paired t-test, P< 0.05. Data shown represent he 
mean + S.D. of triplicate determinations in a single experiment; two 
additional experiments produced similar esults. 
receptor, we were able to selectively study the sub-population 
of cells that have taken up the cDNAs. As illustrated in Fig. 
1A, addition ofhCG (5 ng/ml) to transfected 293 cells resulted 
in a 20-fold increase in intracellular cAMP levels. In the pres- 
ence of 100 nM of melatonin, the hCG-stimulated cAMP accu- 
mulation was reduced by about 50%. In contrast, 100 nM 
melatonin did not significantly inhibit the hCG-stimulated 
cAMP accumulation i 293 cells transfected with LHR alone 
(P > 0.9). Other indoleamines such as 2-iodomelatonin, 6-hy- 
droxymelatonin, and N-acetylserotonin at 100 nM were able to 
inhibit the hCG response to similar magnitudes (unpublished 
results). The melatonin-induced inhibitory effect was dose de- 
pendent (Fig. 1B) and sensitive to PTX treatment (Fig. 1A), 
indicating the involvement of Gi proteins. Our results are in 
accordance with similar reports using NIH-3T3 or CHO cells 
[2,3]. 
Many Gi-coupled receptors have the ability to stimulate the 
formation of cAMP by activating AC 1I [8-11]. As a Gi-coupled 
receptor, the melatonin receptor may also possess the ability to 
regulate AC II. We examined this hypothesis by co-transfecting 
293 cells with cDNAs encoding AC II [16], ~s-Q227L, and 
melatonin receptor. The inclusion of ~s-Q227L (a constitutively 
active mutant of c¢ S harboring a point mutation at codon 227) 
is necessary because Gi-coupled receptors activate AC II by 
releasing fly subunits, and the stimulatory actions of f ly sub- 
units require the presence of GTP-bound ~s [8,17]. As shown 
in Fig. 2, activation of the melatonin receptor stimulated the 
cAMP accumulation by 80-120% over basal values. The mela- 
tonin-induced stimulatory response was apparently mediated 
by G~-like proteins as the increase in cAMP accumulation was 
completely blocked by PTX treatment (Fig. 2). The significance 
of this finding is presently unclear. Thus far, no report on 
melatonin-induced stimulation of cAMP accumulation has 
been documented. Because the melatonin receptor can inhibit 
as well as stimulate different isoforms of adenylyl cyclase, the 
net change in intracellular cAMP will depend on the relative 
abundance of the various isozymes of adenylyl cyclase. In the 
absence of AC II, the endogenous type I, III, and VI adenylyl 
cyclases [18] were inhibited by the activated melatonin receptor 
(Fig. 1A). By over-expressing AC II in 293 cells, the inhibitory 
response of melatonin was converted to a stimulatory signal 
(Fig. 2). It should also be noted that thefly-induced stimulation 
of AC II absolutely required the presence of GTP-bound as [8]. 
Studies using forskolin to stimulate adenylyl cyclases cannot 
provide the proper environment for G~-coupled receptors to 
activate AC II, Interestingly, melatonin has been shown to 
potentiate the vasoactive intestinal peptide-stimulated cAMP 
accumulation i human lymphocytes [19]. Whether the mela- 
tonin response in lymphocytes i due to fly-mediated stimula- 
tion of AC II remains to be determined. 
Another property shared by many Gi-coupled receptors is 
their ability to functionally interact with the PTX-insensitive Gz 
protein [20] in the regulation of adenylyl cyclases [9-13]. Thus 
we sought to examine if similar coupling between Gz and the 
melatonin receptor exists. In 293 cells co-transfected with 
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Fig. 2. Stimulation of AC II by the melatonin receptor. 293 cells were 
co-transfected with cDNAs encoding the AC II (0.25/lg/ml) and ~s- 
Q227L (0.025/~g/ml), with or without the melatonin receptor (0.25 
/lg/ml). Transfected cells were labelled with [2-3H]adenine with or with- 
out PTX as in the legend to Fig. 1 and subsequently assayed for cAMP 
accumulation i  the absence or presence of melatonin. *Melatonin 
significantly stimulated the AC II activity; paired t-test, P < 0.05. Data 
shown represent the mean _+ S.E.M. of triplicate determinations from 
three independent experiments. 
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Fig. 3 Melatonin receptor coupling to the PTX-insensitive c~. (A) 293 
cells were co-transfected with cDNAs encoding the LHR (0.15/~g/ml) 
and the melatonin receptor (0.25 /~g/ml) with or without ct~ (0.125 
/zg/ml). Transfected cells were treated in the absence orpresence ofPTX 
(100 ng/ml) and assayed for cAMP accumulation i  the presence of 
hCG (5 ng/ml) with or without 100 nM melatonin. Results are ex- 
pressed as percent inhibition of the hCG-stimulated response. *PTX 
significantly attenuated the melatonin-induced inhibitory response; 
paired Bonferroni t-test, P < 0.05. (B) 293 cells were co-transfected with 
cDNAs encoding the AC II (0.25/lg/ml), c(~-Q227L (0.025/tg/ml), the 
melatonin receptor (0.25/tg/ml) and with or without ~ (0.125/tg/ml). 
Transfected cells were treated in the absence or presence ofPTX (100 
ng/ml) and assayed for cAMP accumulation in the presence of100 nM 
melatonin. Results are expressed aspercent stimulation over the basal 
activity by melatonin. *Melatonin significantly stimulated the AC II 
activity; paired t-test, P < 0.05. Data in each panel represent triplicate 
determinations i  a single xperiment; two independent experiments 
yielded similar esults. 
cDNAs encoding the LHR, melatonin receptor and the ct sub- 
unit of Gz (c~z), the melatonin-mediated inhibition of hCG re- 
sponse became insensitive to PTX treatment (Fig. 3A). How- 
ever, in the absence of ~z co-expression, PTX-mediated inacti- 
vation of endogenous ~ in the transfected 293 cells effectively 
abolished the response to melatonin (Fig. 3A). Likewise, to test 
whether the melatonin receptor can utilize G~ to stimulate AC 
II, we co-transfected 293 cells with cDNAs encoding the AC 
II, c~-Q227L, and melatonin receptor in the absence or presence 
of ~.  In the absence of ~,  the melatonin-stimulated cAMP 
accumulation was almost abolished following PTX-mediated 
inactivation of endogenous ~i(Fig. 3B). However, in cells co- 
expressing c~ z and the melatonin receptor, PTX only partially 
blocked the indoleamine-mediated s imulation of cAMP accu- 
mulation (Fig. 3B), presumably by inactivating the contribution 
by endogenous Gi proteins. These results suggest hat ~z can 
indeed couple to the melatonin receptor, both for the inhibition 
of endogenous adenylyl cyclases and stimulation of AC II. 
There is no indication of any physiological significance of Gz 
coupling to the melatonin receptor, but it is interesting to note 
that both are present in the retina [1,20]. More importantly, 
PTX-insensitive G proteins appear to link melatonin receptors 
to inhibition of adenylyl cyclase in the ovine pars tuberalis [21]. 
Since the activation of AC II by G~-coupled receptors is 
mediated by the fl), subunits [8,17], one could detect receptor-G 
protein interactions in this system. For those G proteins that 
can functionally interact with the melatonin receptor, the re- 
leased fly subunits would subsequently stimulate AC II. Taking 
advantage ofthis system, we examined the possible replacement 
of endogenous ~ polypeptides by other PTX-insensitive a sub- 
units in transfected 293 cells. In particular, we wanted to test 
the capacity of the melatonin receptor to interact with Gq and 
G]3 which regulate phospholipase C [22] and the Na+/H + an- 
tiporter [23], respectively. Cells were co-transfected with 
cDNAs encoding the AC II, c~s-Q227L, melatonin receptor, and 
an a subunit from either Gz, Gq, G12, or GL3. The transfected 
cells were then labelled with [2-3H]adenine in the absence or 
presence of PTX prior to stimulation by melatonin. As shown 
in Fig. 4, neither Ctq, cq2, nor ~3 was able to replace the en- 
dogenous cq in melatonin-induced activation ofAC II, whereas 
the melatonin response was not suppressed by PTX in cells 
co-expressing ~. Significant enhancement of the melatonin- 
induced stimulation of cAMP accumulation was observed in 
cells co-expressing ~ (Figs. 3B and 4). We have previously 
examined this phenomenon i  other receptor systems and as- 
cribed the enhancement effect to an increase in receptor-releas- 
able pool of fly subunits which is due to the provision of 
e~ 
e~ 
o 
o 
300" 
200 
100 
q¢ 
q¢ 
q¢ 
1 -PTX 
I + PTX 
q¢ 
0 ~ 
pcDNAI (It z OLq (1[,12 O[,13 
Fig. 4. Melatonin receptor coupling to other PTX-insensitive G pro- 
teins. 293 cells were co-transfected as in the legend to Fig. 3B, except 
where indicated, ctz was replaced by either CZq, ~12, cq3, or the control 
vector pcDNAI. Transfected cells were treated with or without PTX 
(100 ng/ml) and assayed for cAMP accumulation i the absence or 
presence of100 nM melatonin. Results are expressed aspercent stimu- 
lation over the basal activity by melatonin, *Melatonin significantly 
stimulated the AC II activity; paired t-test, P < 0,05. Data represent 
triplicate determinations i  asingle xperiment; two independent exper- 
iments yielded similar esults. 
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exogenous ~z subunit [9,11]. Potentiation of the melatonin re- 
sponse was specific and was not observed in cells co-expressing 
C~q, ~2, or ~3 (Fig. 4). In fact, expression of ~q or at3 signifi- 
cantly (P < 0.05) inhibited the melatonin-mediated AC II re- 
sponse. Inhibitions een with these a subunits are presumably 
due to their ability to scavenge free fly subunits that have been 
released by activated melatonin receptors, thus preventing the 
fly subunits from stimulating AC II. These results indicate a 
lack of coupling between the melatonin receptor and the a 
subunits of Gq, G12, and G13. Although we were unable to 
demonstrate coupling between the melatonin receptor and Gq, 
it does not necessarily rule out the possibility that the receptor 
can regulate phospholipase C. There is presidence that the 
complement C5a receptor selectively interacts with Gz6, but not 
with Gq/G 11, to stimulate phospholipase C [24]. Moreover, re- 
ports of melatonin-mediated stimulation of phospholipase C 
are accumulating [25]. 
In summary, the present study is the first demonstration that 
the cloned Xenopus melatonin receptor can couple to a PTX- 
insensitive G protein, Gz, to either stimulate or inhibit different 
isoforms of adenylyl cyclases. Our findings indicate a lack of 
coupling to 6q, 612, or G~3 by the melatonin receptor. 
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